ZFIN ID: ZDB-FISH-150901-4256
Fish name: irf8st95/st95
Genotype: irf8st95/st95
Targeting Reagent: none
HUMAN DISEASE MODELED by irf8st95/st95
No data available
GENE EXPRESSION
Gene expression in irf8st95/st95
Reporter gene expression No data available
PHENOTYPE
Phenotype in irf8st95/st95
Phenotype Conditions Figures
axon regeneration decreased occurrence, abnormal transection: spinal cord Fig. 2Fig. 5Fig. 7Fig. 9 from Tsarouchas et al., 2018
axon regeneration decreased occurrence, abnormal transection: spinal cord, chemical treatment by environment: pomalidomide Fig. 5 from Tsarouchas et al., 2018
axon regeneration occurrence, ameliorated transection: spinal cord, chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Fig. 7 from Tsarouchas et al., 2018
axon regeneration occurrence, normal transection: spinal cord Fig. 5 from Tsarouchas et al., 2018
axon regeneration occurrence, normal transection: spinal cord, chemical treatment by environment: pomalidomide Fig. 5 from Tsarouchas et al., 2018
brain lacks all parts of type microglial cell, abnormal standard conditions Fig. 4 with image from Shen et al., 2016
cell death increased occurrence, abnormal transection: spinal cord Fig. 7 from Tsarouchas et al., 2018
cell death increased occurrence, ameliorated transection: spinal cord, chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Fig. 7 from Tsarouchas et al., 2018
locomotion decreased process quality, abnormal transection: spinal cord Fig. 2Fig. 7 from Tsarouchas et al., 2018
locomotion process quality, ameliorated transection: spinal cord, chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Fig. 7 from Tsarouchas et al., 2018
macrophage absent, abnormal transection: spinal cord Fig. 2 from Tsarouchas et al., 2018
macrophage absent, abnormal fungal treatment by injection: Cryptococcus neoformans Fig. 2 from Davis et al., 2016
macrophage absent, abnormal standard conditions Fig. 2 from Tsarouchas et al., 2018
Fig. 2 with imageFig. 5 with image from Shiau et al., 2015
microglial cell absent, abnormal standard conditions Fig. 1 with image from Shiau et al., 2015
neutrophil increased amount, abnormal standard conditions Fig. 2 with image from Shiau et al., 2015
optic tectum apoptotic cell clearance decreased occurrence, abnormal standard conditions Fig. 4 with image from Shen et al., 2016
regenerating tissue il1b expression increased amount, abnormal transection: spinal cord Fig. 8 from Tsarouchas et al., 2018
regenerating tissue macrophage mpeg1.1 expression absent, abnormal transection: spinal cord Fig. 2 from Tsarouchas et al., 2018
regenerating tissue neutrophil decreased amount, abnormal transection: spinal cord, chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Fig. 7 from Tsarouchas et al., 2018
regenerating tissue neutrophil increased amount, abnormal transection: spinal cord Fig. 9 from Tsarouchas et al., 2018
response to fungus process quality, abnormal fungal treatment by injection: Cryptococcus neoformans Fig. 2 from Davis et al., 2016
trunk macrophage mpeg1.1 expression absent, abnormal transection: spinal cord Fig. 2 from Tsarouchas et al., 2018
trunk macrophage mpeg1.1 expression absent, abnormal standard conditions Fig. 2 from Tsarouchas et al., 2018
trunk ventral region mpeg1.1 expression absent, abnormal standard conditions Fig. 2 from Tsarouchas et al., 2018
trunk ventral region mpeg1.1 expression absent, abnormal transection: spinal cord Fig. 2 from Tsarouchas et al., 2018
whole organism tgfb1a expression decreased amount, abnormal transection: spinal cord Fig. 4 from Tsarouchas et al., 2018
whole organism tnfa expression decreased amount, abnormal transection: spinal cord, chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Fig. 7 from Tsarouchas et al., 2018
whole organism tgfb3 expression decreased amount, abnormal transection: spinal cord Fig. 4 from Tsarouchas et al., 2018
whole organism il1b expression decreased amount, abnormal transection: spinal cord, chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor Fig. 7 from Tsarouchas et al., 2018
whole organism decreased life span, normal bacterial treatment by injection: Pseudomonas aeruginosa PAK Fig. 6 from Rosowski et al., 2016
whole organism tnfa expression increased amount, abnormal transection: spinal cord Fig. 4 from Tsarouchas et al., 2018
whole organism il1b expression increased amount, abnormal transection: spinal cord Fig. 4Fig. 8 from Tsarouchas et al., 2018

CITATIONS  (7)